HEMATOPOETIC STEM CELL TRANSPLANTATION WITH CURRENT PERSPECTIVE IS SAFE FOR MUCOPOLYSACCHARIDOSIS TYPE VI PATIENTS
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
dc.identifier.other
WOS:001365375002060
dc.description.volume
dc.description.issue
Publisher
SPRINGERNATURE
DOI
Abstract
50th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Glasgow, SCOTLAND, APR 14-17, 2024